HP Inc.
HPQ
$32.04
-2.76%
HP Inc. is a global technology hardware company whose two core businesses are Personal Systems (commercial and consumer PCs, workstations, and peripherals) and Printing (consumer and commercial printers, supplies, and services), operating in the highly competitive computer hardware industry. The company is a scale-driven market leader and one of the two dominant PC vendors globally, distinguished by a fully outsourced manufacturing model, heavy reliance on channel partners, and a geographic footprint in which roughly two-thirds of sales come from outside the United States. The current investor narrative centers on whether an AI-PC refresh cycle and printing margin recovery can offset the structural decline of the legacy print supplies business, with the most recent quarterly earnings call explicitly framed around margin recovery and AI PC momentum. That bull case is being contested by a tariff-driven cost backdrop and a wave of cautious sell-side ratings, while recent headlines highlight strong international revenue trends alongside skepticism that earnings beats have been aided by one-time items such as tariff rebates.…
HPQ
HP Inc.
$32.04
Related headlines
Investment Opinion: Should I buy HPQ Today?
The synthesized recommendation is Hold. HPQ presents a classic value trap vs. value opportunity debate: the stock trades at a deep discount (10.4x PE, 0.47x PS) with a 4.16% dividend yield, but it is also 13.8% above the consensus analyst target of $29.66 and carries a 'hold' consensus with no recent Buy ratings. The core thesis is that the market is pricing in terminal decline, but the company is showing revenue stabilization (8.99% YoY growth) and margin recovery potential; however, the risk/reward is skewed unfavorably after an 88% six-month rally.
Supporting evidence for a Hold includes: (1) valuation is undeniably cheap at 10.4x trailing PE and 0.47x PS, well below the technology sector and near the low end of HPQ's historical PS range; (2) revenue growth has reaccelerated to 8.99% YoY, with three consecutive quarters of stable ~$14.4 billion revenue; (3) free cash flow is robust at $3.779 billion TTM, comfortably covering dividends and buybacks; and (4) the dividend yield of 4.16% with a 43% payout ratio provides income support. However, these positives are offset by negative equity, thin net margins (4.57%), and a forward PE above the trailing PE, implying earnings decline.
Key risks that could invalidate the thesis include: (1) margin compression continuing, with Q2 2026 net income down sequentially and EBITDA at a four-quarter low; (2) the AI-PC refresh cycle failing to materialize, leaving Personal Systems revenue stagnant; and (3) tariff costs and international exposure (two-thirds of sales) hurting profitability. The rating would upgrade to Buy if the stock pulls back to the analyst average target of $29.66 or if gross margins sustainably exceed 21% with revenue growth above 10%. It would downgrade to Sell if revenue growth decelerates below 5% or if free cash flow falls below $3 billion. Relative to its own history and peers, HPQ appears undervalued on absolute multiples, but the market is correctly pricing in structural challenges; the stock is fairly valued at best given the risks.
Sign up to view all
HPQ 12-Month Price Forecast
HPQ presents a balanced risk/reward at current levels. The bull case rests on genuine revenue acceleration, deep value multiples, and a 4.16% dividend yield, but the stock has already rallied 88% in six months and trades above the consensus analyst target with a 'hold' rating. The bear case is supported by margin compression, negative equity, and earnings quality concerns. The most likely scenario is a base case where the stock consolidates around $28-$32 as the market awaits evidence of sustainable margin recovery. I would upgrade to bullish if gross margins exceed 21% for two consecutive quarters and revenue growth accelerates above 10%, or downgrade to bearish if free cash flow falls below $3 billion or the dividend is cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on HP Inc.'s 12-month outlook, with a consensus price target around $29.66 and implied upside of -7.4% versus the current price.
Average Target
$29.66
0 analysts
Implied Upside
-7.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$19 - $72
Analyst target range
Coverage on HPQ is broad with 17 analysts, but sentiment is decidedly cautious: the consensus recommendation is "hold" with a recommendation mean of 3.28 (where higher values indicate more bearish ratings), and the average target price of $29.66 implies roughly 13.8% downside from the current price of $34.40. The distribution of institutional ratings is heavily skewed to the bearish side, with recent actions including Goldman Sachs at Sell, B of A Securities, Barclays, Morgan Stanley, and Wells Fargo all at Underperform or Underweight, while UBS, Citigroup, JP Morgan, and TD Cowen sit at Neutral or Hold — notably, there are no recent Buy ratings in the provided data. This means the stock is trading well above the consensus target, a rare and technically bearish configuration that suggests either the market is pricing in a fundamental inflection the sell-side has not yet modeled, or the rally has overshot fundamentals. The target range is extraordinarily wide, from a low of $19.00 to a high of $72.00, a spread of nearly 4x that signals very low conviction and high disagreement about HPQ's future. The $72.00 high target implies a scenario of substantial multiple expansion and successful AI-PC-driven margin recovery that would justify a PE in the low-to-mid teens on higher earnings, while the $19.00 low target prices in a return to the 52-week low and reflects fears of margin compression, tariff cost pressure, and continued print decline. The consensus forward EPS estimate of $4.11 (range $3.95-$4.33) on estimated revenue of $68.1 billion (range $66.0-$70.9 billion) implies modest growth, and the fact that the stock trades above the average target despite a hold consensus means the risk/reward is skewed unfavorably for new buyers at current levels — the burden of proof is on the bulls to demonstrate that the Q3 beat, which some analysts attributed to one-time tariff rebates, is repeatable.
Drowning in data?
Find the real signal!
Bulls vs Bears: HPQ Investment Factors
The bear case currently has stronger evidence, primarily because the stock trades 13.8% above the consensus analyst target of $29.66 with a 'hold' consensus and no recent Buy ratings. While the bull case rests on genuine revenue acceleration (8.99% YoY), deep value multiples (10.4x PE, 0.47x PS), and strong free cash flow ($3.779 billion), these positives are well-known and largely priced in after an 88% six-month rally. The most important tension is whether the AI-PC refresh cycle and margin recovery can sustainably lift earnings enough to justify the current price, or whether the rally has overshot fundamentals and will revert toward the analyst average target. The resolution of this debate hinges on whether Q3's earnings beat—partially attributed to one-time tariff rebates—proves repeatable in coming quarters.
Bullish
- Revenue growth accelerating: Q2 2026 revenue of $14.408 billion grew 8.99% year-over-year, a sharp improvement from the $13.220 billion reported in the year-ago quarter. This reacceleration, combined with three consecutive quarters of stable ~$14.4 billion revenue, suggests the business has stabilized and is benefiting from an AI-PC refresh cycle.
- Deep value valuation: HPQ trades at a trailing PE of 10.36x and a forward PE of 10.96x, with a price-to-sales ratio of just 0.47x and EV/EBITDA of 8.16x. These multiples are well below the broader technology sector and near the low end of HPQ's historical PS range of 1.3x to 2.6x, implying the market is pricing in terminal decline rather than stabilization.
- Strong free cash flow and dividend: Trailing free cash flow is $3.779 billion, and Q2 2026 free cash flow of $756 million comfortably funded $170 million of capex, $274 million of dividends, and $100 million of buybacks. The 4.16% dividend yield with a sustainable 43% payout ratio provides an attractive income stream while the company returns capital.
- Powerful technical momentum: HPQ is up 88.3% over six months and 55.5% year-to-date, massively outperforming SPY by 70.8 and 43.8 percentage points respectively. The stock is trading at $34.40, near the top of its 52-week range ($17.56-$36.23), with accelerating momentum (+14.9% in the past month) that suggests a fresh catalyst-driven move.
Bearish
- Trading above consensus target: The average analyst target price is $29.66, implying 13.8% downside from the current $34.40 price. With a consensus recommendation of 'hold' (mean 3.28) and no recent Buy ratings, the stock is trading above the sell-side's fair value estimate, a rare and technically bearish configuration.
- Margin compression and earnings decline: Net income declined sequentially from $545 million in Q1 2026 to $450 million in Q2 2026, and Q2 EBITDA of $710 million was the lowest in four quarters. Gross margin fell to 20.93% from 21.03% a year ago, and the forward PE (10.96x) exceeding the trailing PE (10.36x) implies the market expects flat-to-lower earnings ahead.
- Balance sheet fragility: HPQ has negative shareholders' equity (debt-to-equity of -31.45, ROE of -7.31%), a current ratio of 0.767, and a quick ratio of 0.489, indicating tight liquidity. Years of buybacks and dividends exceeding retained earnings have eroded the capital base, leaving little margin for error if cash flow deteriorates.
- Earnings quality concerns: Recent headlines highlight that the Q3 earnings beat was aided by one-time tariff rebates, and analysts remain skeptical about the sustainability of the beat. With 17 analysts covering the stock and a recommendation mean of 3.28, the sell-side is unconvinced that the margin recovery is durable.
HPQ Technical Analysis
HPQ is in a powerful, sustained uptrend: the stock is up 21.8% over the past year, 55.5% year-to-date, and 88.3% over six months, with the current price of $34.40 sitting at roughly 92% of its 52-week range (52-week low of $17.56, 52-week high of $36.23). That positioning near the top of the annual range signals strong momentum but also meaningful overextension risk, particularly after such a steep six-month advance. The stock has also decisively outperformed the market, with relative strength of +6.8 percentage points over one year and +43.8 points year-to-date versus SPY, confirming that this is leadership rather than beta-driven drift. Recent momentum is accelerating rather than fading: HPQ has gained 14.9% in the past month and 46.4% over three months, even as SPY fell 0.96% and rose just 2.0% over the same periods, producing relative strength of +15.9 and +44.4 points respectively. The 1-month trend (+14.9%) is directionally consistent with the 1-year trend (+21.8%) but far steeper, implying the move is being driven by a fresh catalyst — likely the Q3 earnings beat and raised guidance — rather than a simple continuation of the prior drift. With a short ratio of 5.06 days and volume of roughly 35.5 million shares, there is a meaningful short base that could amplify further upside on continued strength, though it also raises the risk of a sharp unwind if momentum stalls. Key technical levels are well defined: support sits at the 52-week low of $17.56, with intermediate support around the $30-$31 area where the stock consolidated in late August and early September, while resistance is the 52-week high of $36.23, just 5.3% above the current $34.40 price. A clean breakout above $36.23 would confirm the uptrend and likely open a new leg higher, whereas a breakdown below $30 would signal that the September spike was a blow-off move and expose the $27-$28 zone. With a beta of 1.205, HPQ is about 21% more volatile than the market, and its maximum drawdown of -37.99% over the measured period underscores that position sizing should account for materially larger swings than the index.
Beta
1.21
1.21x market volatility
Max Drawdown
-38.0%
Largest decline past year
52-Week Range
$18-$36
Price range past year
Annual Return
+13.4%
Cumulative gain past year
| Period | HPQ Return | S&P 500 |
|---|---|---|
| 1m | +7.8% | +1.0% |
| 3m | +37.6% | +5.5% |
| 6m | +65.8% | +19.9% |
| 1y | +13.4% | +16.0% |
| ytd | +44.8% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HPQ Fundamental Analysis
HPQ's revenue trajectory has reaccelerated: the most recent quarter (ending 2026-04-30) delivered revenue of $14.408 billion, up 8.99% year-over-year, a clear improvement from the $13.220 billion reported in the year-ago quarter. Sequentially, revenue has been remarkably stable at roughly $14.4 billion in each of the last three reported quarters ($14.639B in Q4 2025, $14.438B in Q1 2026, $14.408B in Q2 2026), indicating the business has stabilized after the prior year's softness. By segment, Personal Systems is the dominant driver at $10.213 billion, versus $4.195 billion for Printing and a negligible $1 million in Corporate Investments, meaning the PC business carries the growth burden while print remains the profit engine. The key question for the investment case is whether AI-PC demand can lift Personal Systems revenue enough to offset the secular erosion of high-margin print supplies, and the 8.99% YoY growth suggests that dynamic is currently working in HPQ's favor. Profitability is solid but thin, as is typical for hardware: Q2 2026 net income was $450 million on a 3.12% net margin, with gross margin of 20.93% and operating margin of 4.25%, while the trailing valuation data show a 4.57% net margin, 19.98% gross margin, and 6.55% operating margin. Margins have been compressing on a sequential basis — gross margin fell from 20.93% in Q2 2026 versus 19.64% in Q1 2026 and 19.84% in Q4 2025, while net income declined from $545 million in Q1 2026 to $450 million in Q2 2026 — and the Q2 EBITDA of $710 million was the lowest of the last four quarters. The company remains firmly profitable with positive EPS of $0.49 in the most recent quarter, but the margin trajectory is the central fundamental debate, and management's emphasis on margin recovery implies the current level is viewed as a trough rather than a steady state. Balance-sheet quality is mixed: HPQ generates substantial cash with trailing free cash flow of $3.779 billion and Q2 2026 free cash flow of $756 million, but liquidity is tight with a current ratio of 0.767 and a quick ratio of 0.489, and the reported debt-to-equity of -31.45 and ROE of -7.31 reflect negative shareholders' equity rather than a healthy capital structure. The negative equity stems from years of buybacks and dividends exceeding retained earnings, and the payout ratio of 43.0% with a 4.16% dividend yield means capital returns remain a core part of the thesis even as they constrain balance-sheet flexibility. Positively, interest coverage is comfortable at roughly 6.2x, the cash conversion cycle is negative at about -19 days (a sign of favorable working-capital dynamics), and Q2 2026 operating cash flow of $926 million comfortably funded $170 million of capex, $274 million of dividends, and $100 million of buybacks — so the company is self-funding, but with little margin for error if cash flow deteriorates.
Quarterly Revenue
$14.4B
2026-04
Revenue YoY Growth
+9.0%
YoY Comparison
Gross Margin
20.9%
Latest Quarter
Free Cash Flow
$3.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HPQ Overvalued?
Because HPQ is profitable — Q2 2026 net income of $450 million and trailing EPS of $0.097 — the appropriate primary metric is the price-to-earnings ratio, and the stock trades at a trailing PE of 10.36x versus a forward PE of 10.96x. The forward multiple being slightly higher than the trailing multiple is unusual and implies the market expects essentially flat-to-lower earnings ahead, consistent with the sequential decline in net income from $545 million to $450 million and the fact that the consensus forward EPS estimate of $4.11 is being applied against a depressed trailing base. On a price-to-sales basis, HPQ trades at just 0.47x, and its EV/Sales of 0.633x and EV/EBITDA of 8.16x are both low in absolute terms, reflecting the market's skepticism about the durability of hardware margins. Relative to the broader Technology sector, HPQ screens as a deep value name: a PE of 10.36x and PS of 0.47x are well below the multiples typically commanded by technology companies, and even the EV/EBITDA of 8.16x is modest for a business with $3.779 billion of trailing free cash flow. The discount is partly justified — HPQ has negative book value (PB of -75.65), a 4.57% net margin, and a structurally challenged print business — but the gap between a 10.4x PE and the sector's growth-oriented multiples suggests the market is pricing in terminal decline rather than the AI-PC-driven stabilization management is guiding toward. Historically, HPQ's own PE has ranged from roughly 6.7x to 15.5x over the past several years, and the current 10.36x sits in the middle of that band, neither a screaming bargain nor an obvious trap relative to its own history. The stock's PS ratio of 0.47x, however, is near the low end of its historical range — prior periods saw PS ratios of 1.3x to 2.6x — which reflects both the compression in the multiple and the fact that the share count has fallen through buybacks while revenue has stabilized. The key valuation tension is that the stock has rallied 88% in six months while the PE has stayed near 10x, meaning the entire move has been driven by earnings expectations rather than multiple expansion; if the AI-PC cycle delivers, the multiple could re-rate, but if margins fail to recover, the low absolute multiple will prove to have been justified.
PE
10.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 3x~16x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. HPQ carries negative shareholders' equity (debt-to-equity of -31.45) and a current ratio of 0.767, indicating limited liquidity buffer. The company's net margin is thin at 4.57%, and sequential net income declined from $545 million in Q1 2026 to $450 million in Q2 2026, with Q2 EBITDA of $710 million being the lowest in four quarters. Free cash flow of $3.779 billion is strong, but the 43% payout ratio and ongoing buybacks leave little room for error if cash flow deteriorates. Additionally, the Printing segment, which is the profit engine, faces structural decline in high-margin supplies, while Personal Systems (71% of revenue) is a low-margin, highly competitive business.
Market and competitive risks are elevated. HPQ trades at a forward PE of 10.96x, which is above the trailing PE of 10.36x, implying the market expects earnings to decline. The stock is trading 13.8% above the consensus analyst target of $29.66, and the recommendation mean of 3.28 (hold) with no recent Buy ratings suggests limited institutional support. With a beta of 1.205, HPQ is 21% more volatile than the market, and its 88% six-month rally has left it vulnerable to profit-taking. Competitive pressures from Dell, Lenovo, and Apple in PCs, and from Canon and Epson in printing, are relentless. Tariff risks are also material, given that two-thirds of sales are international and manufacturing is fully outsourced.
In a worst-case scenario, a global recession or a sharper-than-expected decline in PC demand could trigger a re-rating. If margins fail to recover and the AI-PC cycle disappoints, the stock could fall to the analyst low target of $19.00, representing a 44.8% decline from the current $34.40. A more moderate bear case would see the stock retest its 52-week low of $17.56, a 49% drop. The maximum drawdown over the measured period was -37.99%, indicating that such declines are within historical experience. Investors could lose nearly half their capital in an adverse scenario, especially if the stock breaks below the $30 support level and momentum unwinds.
FAQ
The key risks are ranked as follows: (1) Financial risk: negative shareholders' equity (debt-to-equity of -31.45) and a current ratio of 0.767 indicate limited liquidity buffer, with net income declining sequentially to $450 million in Q2 2026. (2) Market/valuation risk: the stock trades 13.8% above the consensus target of $29.66, and with a beta of 1.205, it is 21% more volatile than the market, exposing investors to sharp drawdowns (max drawdown of -37.99%). (3) Competitive risk: HPQ faces intense competition in PCs from Dell, Lenovo, and Apple, and in printing from Canon and Epson, while the high-margin print supplies business faces secular decline. (4) Macro/tariff risk: two-thirds of sales are international, and tariff costs threaten margins, with recent earnings beats partially attributed to one-time tariff rebates.
The 12-month forecast has three scenarios: bull case (25% probability) with a target range of $45-$72, assuming a successful AI-PC refresh cycle and margin expansion; base case (55% probability) with a target range of $28-$32, assuming moderate growth and stable margins, aligning with the analyst average target of $29.66; and bear case (20% probability) with a target range of $17.56-$22, assuming a recession or disappointing AI-PC demand. The base case is most likely, implying a modest pullback from the current $34.40 price. The key assumption behind the base case is that revenue grows 5-7% YoY and gross margins hold around 20-21%. The wide analyst target range of $19 to $72 reflects very low conviction and high disagreement about HPQ's future.
HPQ appears undervalued on absolute multiples, trading at a trailing PE of 10.36x, forward PE of 10.96x, and price-to-sales of 0.47x, all well below the technology sector and near the low end of its historical PS range of 1.3x to 2.6x. However, the forward PE exceeding the trailing PE implies the market expects earnings to decline, and the stock trades 13.8% above the consensus analyst target of $29.66, suggesting it is overvalued relative to sell-side expectations. The discount is partly justified by negative book value (PB of -75.65), a thin 4.57% net margin, and structural challenges in the Printing segment. The market is pricing in terminal decline, but if the AI-PC cycle delivers, the multiple could re-rate; if not, the low multiple will prove justified.
HPQ is a good buy only for specific investor profiles: value-oriented investors seeking a 4.16% dividend yield and deep-value multiples (10.4x PE, 0.47x PS) may find it attractive, but the stock trades 13.8% above the consensus analyst target of $29.66 and carries a 'hold' consensus with no recent Buy ratings. The risk/reward is skewed unfavorably after an 88% six-month rally, with the biggest downside risk being a reversion to the analyst low target of $19.00 (45% downside). For long-term income investors, the dividend appears sustainable with a 43% payout ratio and $3.779 billion in trailing free cash flow, but negative equity and a current ratio of 0.767 warrant caution. A better entry point would be near the $30 support level or the analyst average target of $29.66.
HPQ is more suitable for long-term investment than short-term trading, given its 4.16% dividend yield, deep-value valuation, and the multi-year nature of the AI-PC refresh cycle. However, the stock's high beta of 1.205 and maximum drawdown of -37.99% mean short-term traders could profit from momentum but face significant volatility. For long-term investors, the dividend and potential multiple expansion offer a favorable risk/reward if the margin recovery thesis plays out, but the negative equity and structural print decline warrant a minimum holding period of at least 2-3 years to allow the AI-PC cycle to mature. Short-term traders should be aware that the stock is overextended after an 88% six-month rally and could correct sharply if momentum stalls.
